Zymergen and Arzeda announced today a multi-year agreement to develop strains and processes to manufacture novel, high utility molecules and materials utilizing Arzeda’s pathway and enzyme design and Zymergen’s strain construction capabilities. “The development of new materials was a major driver of technological development over the course of the 20th century. Biology has the potential to drive materials breakthroughs in the 21st century, and Arzeda’s technology can help identify new

Nunc interdum sapien ut mauris maxi us consectetur porta nunc. Con vallislo em ipsum dolor sit amet onsec tet.

Working hour

Mon – Fri: 9 a.m. – 5 p.m.
Sat – Sun: Closed

650 Birmingham St,
London 3000, UK

Follow us: